Phenotypic Susceptibility to Bevirimat in Isolates from HIV-1-Infected Patients without Prior Exposure to Bevirimat

Por Margot, Nicolas A., Gibbs, Craig S., Miller, Michael D.
Publicado em 2010

ATP-Dependent Removal of Nucleoside Reverse Transcriptase Inhibitors by Human Immunodeficiency Virus Type 1 Reverse Transcriptase

Por Naeger, Lisa K., Margot, Nicolas A., Miller, Michael D.
Publicado em 2002

Characterization of HIV-1 Resistance to Tenofovir Alafenamide In Vitro

Por Margot, Nicolas A., Johnson, Audun, Miller, Michael D., Callebaut, Christian
Publicado no Antimicrob Agents Chemother (2015)

Molecular Mechanisms of Resistance to Human Immunodeficiency Virus Type 1 with Reverse Transcriptase Mutations K65R and K65R+M184V and Their Effects on Enzyme Function and Viral Re...

Por White, Kirsten L., Margot, Nicolas A., Wrin, Terri, Petropoulos, Christos J., Miller, Michael D., Naeger, Lisa K.
Publicado em 2002

Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome

Por Abram, Michael E., Ram, Renee R., Margot, Nicolas A., Barnes, Tiffany L., White, Kirsten L., Callebaut, Christian, Miller, Michael D.
Publicado no PLoS One (2017)

Molecular Mechanisms of Tenofovir Resistance Conferred by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing a Diserine Insertion after Residue 69 and Multiple Th...

Por White, Kirsten L., Chen, James M., Margot, Nicolas A., Wrin, Terri, Petropoulos, Christos J., Naeger, Lisa K., Swaminathan, S., Miller, Michael D.
Publicado em 2004

Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir

Por Marchand, Bruno, White, Kirsten L., Ly, John K., Margot, Nicolas A., Wang, Ruth, McDermott, Martin, Miller, Michael D., Götte, Matthias
Publicado em 2007

Prophylactic and Therapeutic Benefits of Short-Term 9-[2-(R)-(Phosphonomethoxy)Propyl]Adenine (PMPA) Administration to Newborn Macaques following Oral Inoculation with Simian Immun...

Por Van Rompay, Koen K. A., Miller, Michael D., Marthas, Marta L., Margot, Nicolas A., Dailey, Peter J., Canfield, Don R., Tarara, Ross P., Cherrington, Julie M., Aguirre, Nancy L., Bischofberger, Norbert, Pedersen, Niels C.
Publicado em 2000

Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness

Por Abram, Michael E., Hluhanich, Rebecca M., Goodman, Derrick D., Andreatta, Kristen N., Margot, Nicolas A., Ye, Linda, Niedziela-Majka, Anita, Barnes, Tiffany L., Novikov, Nikolai, Chen, Xiaowu, Svarovskaia, Evguenia S., McColl, Damian J., White, Kirsten L., Miller, Michael D.
Publicado em 2013

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phas...

Por Tang, Michele W., Rhee, Soo-Yon, Bertagnolio, Silvia, Ford, Nathan, Holmes, Susan, Sigaloff, Kim C., Hamers, Raph L., de Wit, Tobias F. Rinke, Fleury, Herve J., Kanki, Phyllis J., Ruxrungtham, Kiat, Hawkins, Claudia A., Wallis, Carole L., Stevens, Wendy, van Zyl, Gert U., Manosuthi, Weerawat, Hosseinipour, Mina C., Ngo-Giang-Huong, Nicole, Belec, Laurent, Peeters, Martine, Aghokeng, Avelin, Bunupuradah, Torsak, Burda, Sherri, Cane, Patricia, Cappelli, Giulia, Charpentier, Charlotte, Dagnra, Anoumou Y., Deshpande, Alaka K., El-Katib, Ziad, Eshleman, Susan H., Fokam, Joseph, Gody, Jean-Chrysostome, Katzenstein, David, Koyalta, Donato D., Kumwenda, Johnstone J., Lallemant, Marc, Lynen, Lutgarde, Marconi, Vincent C., Margot, Nicolas A., Moussa, Sandrine, Ndung'u, Thumbi, Nyambi, Phillipe N., Orrell, Catherine, Schapiro, Jonathan M., Schuurman, Rob, Sirivichayakul, Sunee, Smith, Davey, Zolfo, Maria, Jordan, Michael R., Shafer, Robert W.
Publicado em 2013